IRIXIRIDEX CORPvs its industry peers
A metric-by-metric comparison of IRIDEX CORP against Electromedical & Electrotherapeutic Apparatus — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRIXThis | $15M#9 | — | 3.1x#7 | 0.3x#1 | — | — | -4.9%#3 | -93.8%#6 | -90.6%#6 | — | -37.5%#8 | — |
| VANI | $121M#2 | — | 6.3x#9 | — | — | 13.3%#5 | — | 139.4%#1 | -1794.0%#9 | — | 6.4%#4 | — |
| OM | $97M#3 | — | 0.9x#2 | 0.8x#3 | 5.1%#7 | 36.2%#3 | -55.8%#8 | -73.1%#5 | -36.5%#2 | 4#2 | -63.0%#10 | — |
| NRXS | $88M#4 | — | 15.4x#10 | 24.7x#8 | 32.9%#5 | 5.4%#6 | -219.4%#10 | -135.7%#7 | — | — | 185.2%#3 | — |
| STEX | $81M#5 | — | 0.5x#1 | 2017.7x#10 | 122.2%#2 | -4379.9%#14 | -177735.0%#13 | -291.1%#10 | — | — | -82.5%#11 | — |
| ECOR | $52M#6 | — | — | 1.6x#4 | 27.2%#6 | -17.5%#8 | -41.1%#7 | — | — | — | -12.5%#6 | — |
| POCI | $46M#7 | — | 2.3x#4 | 2.4x#6 | -0.1%#11 | -95.8%#11 | -29.1%#5 | -28.7%#4 | -51.1%#4 | 3#4 | -15.5%#7 | — |
| QTI | $33M#8 | — | 5.1x#8 | 1.7x#5 | 287.9%#1 | -134.6%#12 | -23.4%#4 | -327.1%#11 | -72.2%#5 | 6#1 | 340.4%#2 | — |
| NXL | $8M#10 | — | 2.7x#5 | 25.6x#9 | 78.8%#4 | -8.1%#7 | -2781.7%#12 | -284.9%#8 | — | — | -61.8%#9 | — |
| NDRA | $5M#11 | — | 3.1x#6 | — | — | 38.9%#2 | — | -393.3%#12 | — | — | -12.1%#5 | — |
| NUWE | $5M#12 | 1.4x#1 | 1.9x#3 | 0.6x#2 | -5.4%#12 | -56.9%#10 | -134.3%#9 | -658.4%#13 | -171.4%#8 | — | -99.2%#12 | — |
| ADMT | — | — | — | — | 4.7%#8 | 18.4%#4 | -4.8%#2 | -17.6%#3 | -43.0%#3 | — | — | — |
| ENDV | — | — | — | — | 85.2%#3 | -495.0%#13 | -2411.7%#11 | — | — | 4#2 | — | — |
| ESMC | — | — | — | — | 0.5%#10 | 184.2%#1 | 1.1%#1 | 2.5%#2 | 16.2%#1 | — | — | — |
| FOCL | $239M#1 | — | 23.6x#11 | 3.4x#7 | 1.6%#9 | -42.1%#9 | -35.0%#6 | -289.5%#9 | -137.6%#7 | 3#4 | 401.6%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3845). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice